Clinical trial
Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
NCT04614974 is registered in ClinicalTrials.gov with Reema Padia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia
- Lead sponsor
- Reema Padia
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- November 18, 2020
- Completion date
- May 17, 2024
- Enrollment
- 65 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastro esophageal reflux, laryngomalacia